Suzanne Chambers
Born
Suzanne Kathleen Bullock
Alma materGriffith University (PhD)
Scientific career
InstitutionsUniversity of Technology, Sydney

Suzanne Kathleen Chambers AO, is a Professor and Dean of the Faculty of Health at Sydney's University of Technology. She specialises in psycho-oncology, and has received Queen's Birthday honours.[1][2] Chambers has worked on psycho-oncology, prostate cancer,[3] health economics and psychological interventions including the distress and adjustments after cancer.[4][5]

Research interests and career

Chambers career began with her work as a hairdresser before she became a registered nurse.[1] She was awarded her PhD from Griffith University, in 2004, and then in 2011 she worked in Preventative Health, at Griffith University. Chambers led their "Strategic Investment in Chronic Disease".[3] Her work on the usefulness of ‘mindfulness’ in cancer treatment as a complementary therapy was reported by The Conversation.[6] Chambers is a health psychologist, as well as Dean. She is both a practitioner and researcher providing psychological support for people with cancer over three decades[7] and she has specialised in prostate cancer.[8][9][10]

As Dean of Health she was recognised in the 2018 Queen's Birthday Honours.[11] Her research has been awarded $28 million in competitive grants.[1] The Cancer Council Queensland, praised the impact of her work on patient recoveries.[12]

Publications

Books

  • Chambers, Suzanne (2013). Facing the Tiger: A guide for men with prostate cancer and the people who love them. Australian Academic Press Group. ISBN 978-1-922117-05-2.

Selected articles

Chambers had an H number of 52 and over 9,500 citations, as at August 2019.[13]

  • Schumacher et al. (2018) Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci, Nature genetics 50:928–936.[14]
  • Eeles et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature genetics 41:1116-1121.[15]
  • Steginga et al. (2000) The supportive care needs of men with prostate cancer Psycho-oncology 10: 66–75.[16]

Awards, honours and recognition

  • 2018 – Chambers was part of the team CAHE which won the Vice Chancellors award for research excellence.[7]
  • 2016 – Chambers won an NHMCR, with $2.8 million in funding for the Centre for Research Excellence in Prostate Cancer Survivorship in Qld.[17]
  • 2012 – She was awarded ARC Future Fellow.[18]
  • 2012 – Chambers was awarded the William Rudder fellowship by the Cancer Council Queensland (CCQ).[12]

References

  1. 1 2 3 "Suzanne Chambers' unconventional (and unrelenting) path to dean of health at UTS". Australian Financial Review. 25 October 2018. Retrieved 23 August 2019.
  2. ↑ "A career in psycho-oncology results in Queen's Birthday Honours". news.griffith.edu.au. Retrieved 23 August 2019.
  3. 1 2 Edith Cowan University, Perth (17 June 2016). "Professor Suzanne Chambers". ECU. Retrieved 23 August 2019.
  4. ↑ "Prostate Org media research forum" (PDF).
  5. ↑ "Suzanne Chambers". The Conversation. Retrieved 23 August 2019.
  6. ↑ Chambers, Suzanne; University, Griffith; AO, Professor Jeff Dunn; Queensl, Cancer Council. "Suzanne Chambers". The Conversation. Retrieved 23 August 2019.
  7. 1 2 Hynard, Author: Gemma. "CAHE Staff win Vice Chancellor's Award for Research Excellence". Centre for Applied Health Economics | Griffith University. Retrieved 23 August 2019. {{cite web}}: |first= has generic name (help)
  8. ↑ "ANZUP - Scientific Advisory Committee". www.anzup.org.au. Retrieved 23 August 2019.
  9. ↑ "Suzanne Chambers | University of Technology Sydney". www.uts.edu.au. Retrieved 23 August 2019.
  10. ↑ "Dr. Suzanne Chambers | Men's Health Research at UBC". menshealthresearch.ubc.ca. Retrieved 23 August 2019.
  11. ↑ "Professor Suzanne Kathleen Chambers". honours.pmc.gov.au. Retrieved 27 August 2019.
  12. 1 2 Durack, Louise. "Top Fellowship for Griffith Health professor". news.griffith.edu.au. Retrieved 23 August 2019.
  13. ↑ "Suzanne Chambers - Google Scholar Citations". scholar.google.com.au. Retrieved 23 August 2019.
  14. ↑ Easton, Douglas F.; Consortium, The PRACTICAL; Collaborators, The UK ProtecT Study; Oncology, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of; Cao, Guangwen; Mitkova, Atanaska; Slavov, Chavdar; Khan, Humera; Farnham, Jim (2009). "Identification of seven new prostate cancer susceptibility loci through a genome-wide association study". Nature Genetics. 41 (10): 1116–1121. doi:10.1038/ng.450. ISSN 1546-1718. PMC 2846760. PMID 19767753. {{cite journal}}: |last3= has generic name (help)
  15. ↑ Eeles, Rosalind A.; Haiman, Christopher A.; Kote-Jarai, Zsofia; Henderson, Brian E.; Chanock, Stephen J.; Wiklund, Fredrik; Easton, Douglas F.; Conti, David V.; Amos, Christopher I. (2018). "Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci". Nature Genetics. 50 (7): 928–936. doi:10.1038/s41588-018-0142-8. ISSN 1546-1718. PMC 6568012. PMID 29892016.
  16. ↑ Yaxley, J.; Heathcote, P.; Gardiner, R. A.; Dunn, J.; Occhipinti, S.; Steginga, S. K. (1 January 2001). "The supportive care needs of men with prostate cancer (2000)". Psycho-Oncology. 10 (1): 66–75. doi:10.1002/1099-1611(200101/02)10:1<66::aid-pon493>3.0.co;2-z. PMID 11180578. S2CID 35135008.
  17. ↑ Durack, Louise. "Griffith research receives $2.8m in funding". news.griffith.edu.au. Retrieved 23 August 2019.
  18. ↑ "Prostate Org Research Forum" (PDF).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.